Takeda Aims for Globalisation with Purchase of Brazilian Company Multilab

By Heather Cartwright

Pharma Deals Review: Vol 2012 Issue 5 (Table of Contents)

Published: 30 May-2012

DOI: 10.3833/pdr.v2012.i5.1747     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Takeda Pharmaceutical is to acquire the Brazilian branded generics and OTC drug company Multilab Indústria e Comércio de Produtos Farmacêuticos for BRL500 M (US$246 M) upfront and up to BRL40 M (US$20 M) in future milestone payments...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details